share_log

港股异动 | 先瑞达医疗-B(06669)涨超4% 公司产品微导管Vericor-14获日本和泰国批准

Changes in Hong Kong stocks | Xianruida Medical-B (06669) rose more than 4%, and the company's product, the microcatheter Vericor-14, was approved by Japan and Thailand

Zhitong Finance ·  Sep 12, 2023 02:42

Zhitong Financial APP learned that Syngenta Medical-B (06669) is now up more than 4%. As of press time, it rose 3.91% to HK $13.3, with a turnover of HK $1.8555 million.

On the news, first Ruida Medical announced that on August 25, 2023, the company's product microcatheter Vericor-14 obtained the product registration approval of the Ministry of Health and Labor of Japan (registration certificate number: 30500BZI00032000). On August 30th, 2023, the microcatheter Vericor-14 received registration approval from the Food and Drug Administration of Thailand (registration number: 66-2-1-2-0012209).

It is reported that the product is suitable for percutaneous coronary and peripheral vascular interventional surgery to guide the guide wire for the location of stenotic vascular lesions, and provide channels for the exchange of guide wire and the delivery of normal saline or diagnostic contrast medium. The company will carry out marketing activities in due course.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment